February 24, 2010Open Access

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Key Points

Key points are not available for this paper at this time.

Abstract

The initiation of antiretroviral therapy during tuberculosis therapy significantly improved survival and provides further impetus for the integration of tuberculosis and HIV services. (ClinicalTrials.gov number, NCT00398996.)

Read Full Paperexternally

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

New England Journal of Medicine

Institutions

Columbia University

Yale University

University of KwaZulu-Natal

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.